Login to Your Account



J.P. MORGAN HEALTHCARE CONFERENCE

Abbvie continues to impress investors after its 2013 spinout from Abbott

By Peter Winter
BioWorld Insight Editor

Thursday, January 16, 2014
SAN FRANCISCO – It has been exactly one year since Abbott spun out its research-based pharmaceuticals business into Abbvie Inc., an independent, publicly traded company. Since that time the company has been a favorite with investors. Will the company be able to repeat that performance going forward?

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription